Company Valuation: Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Capitalization 1 32,746 50,054 38,543 26,748 28,519 28,953 - -
Change - 52.86% -23% -30.6% 6.62% 1.52% - -
Enterprise Value (EV) 32,746 49,007 39,009 25,903 28,519 28,953 28,953 28,953
Change - 49.66% -20.4% -33.6% 10.1% 1.52% 0% 0%
P/E ratio 24.4x 21.2x 28.5x -36.9x 22.2x 19.3x 16.7x 13.8x
PBR 3.61x 4.58x 3.37x 2.62x 2.6x 2.45x 2.16x 1.76x
PEG - 0.3x -0.7x 0x -0x 1.1x 1.1x 0.7x
Capitalization / Revenue 3.24x 3.99x 3.74x 4.11x 3.64x 3.42x 3.2x 3.15x
EV / Revenue 0x 0x 0x 0x 0x 3.42x 3.2x 3.15x
EV / EBITDA 0x 0x 0x -0.06x 0x 16.2x 14.1x 15.4x
EV / EBIT 0x 0x 0x -0x 0x 15.8x 13.7x 11x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Dividend per Share 2 0.3 0.5 0.3 - 0.5 0.21 0.24 -
Rate of return 1.53% 1.67% 1.3% - 2.93% 1.21% 1.38% -
EPS 2 0.8044 1.414 0.8095 -0.4337 0.77 0.9 1.04 1.26
Distribution rate 37.3% 35.4% 37.1% - 64.9% 23.3% 23.1% -
Net sales 1 10,117 12,533 10,318 6,513 7,831 8,472 9,043 9,188
EBITDA 1 1,939 3,271 2,321 -0.422 2,243 1,784 2,058 1,884
EBIT 1 1,569 2,830 1,780 -688.9 1,623 1,835 2,112 2,628
Net income 1 1,344 2,362 1,352 -724.5 1,286 1,509 1,737 2,098
Net Debt - -1,048 465.6 -844.8 - - - -
Reference price 2 19.60 29.96 23.07 16.01 17.07 17.33 17.33 17.33
Nbr of stocks (in thousands) 1,670,705 1,670,705 1,670,705 1,670,705 1,670,705 1,670,705 - -
Announcement Date 4/28/22 4/25/23 4/26/24 4/28/25 4/27/26 - - -
1CNY in Million2CNY
Estimates

P/E ratio, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
19.26x - - 1.21% 4.26B
15.86x1.94x12.1x5.66% 13.81B
28.88x1.69x10.44x1.82% 5.59B
17.1x3.6x11.28x5.88% 5.07B
28.93x - - - 4.2B
17.55x2.24x10.03x2.43% 3.28B
14.77x2.92x12.41x5.45% 1.82B
Average 20.33x 2.48x 11.25x 3.74% 5.43B
Weighted average by Cap. 19.86x 2.27x 11.44x 4.17%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. 002603 Stock
  4. Valuation Shijiazhuang Yiling Pharmaceutical Co., Ltd.